On November 14, 2022, Bruker Corporation, a Nasdaq-listed provider of scientific instruments and analytical and diagnostic solutions, acquired Neurescence Inc., an innovative provider of ultra-light fiber-bundle multiscopes for simultaneous multi-region, optical functional neuroimaging.

Davies Ward Phillips & Vineberg LLP acted as counsel to Bruker, with a team that included Michel Gélinas, Ryan Brun and Michelle Vesely (M&A/Life Sciences); Olivia Khazam (Tax); Gillian Stacey and Benoit Archambault (Technology/IP); and Shari Cohen (Employment).

Torys LLP acted as counsel to Neurescence Inc. with a team led by Jordan Wright.